Skip to content

Author

I. B. Kristensen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Forimtamig, a GPRC5DxCD3 bispecific antibody with a novel 2:1 format, in relapsed/refractory multiple myeloma.

We report the results from a Phase 1 study (NCT04557150) evaluating subcutaneous (SC) forimtamig, a novel GPRC5DxCD3 bispecific antibody with a 2:1 configuration, in relapsed/refractory multiple myeloma (RRMM). After dose-escalation, backfilling at optimized target doses in combination with weekly (step-up: Cycle [C] 1...

Anna Caroline Hasselbalch, Simon J. Harrison, Salomon Manier et al. · 0 citations
Review Open access Oct 2026

Frailty and quality of life in a real-world multiple myeloma population.

The results based on a real-world population show that QoL findings from clinical trial populations cannot directly be applied to frail patients.

K. Rydahl, Sören Möller, T. Horsbøl et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.